DJ Incyte Corp. Stock Underperforms Tuesday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Incyte Corp. $(INCY)$ slipped 1.30% to $123.20 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.17% to 7,670.84 and Dow Jones Industrial Average falling 0.26% to 51,349.92.

Incyte Corp. closed 7.09% short of its 52-week high of $132.60, which the company achieved on July 28th.

The stock underperformed when compared to some of its competitors Tuesday, as Alnylam Pharmaceuticals Inc. $(ALNY)$ fell 0.51% to $254.07, Bio-Techne Corp. (TECH) fell 0.18% to $72.38, and BioMarin Pharmaceutical Inc. $(BMRN)$ rose 0.69% to $59.87.

Trading volume (1.7 M) eclipsed its 50-day average volume of 1.6 M.

Data source: Dow Jones Market Data, FactSet. Data compiled September 29, 2026.